![]() |
市场调查报告书
商品编码
1645305
2018 - 2032 年骨科手术人工智慧市场评估(按组件类型、技术、解剖结构、最终用户、地区、机会和预测)AI in Orthopedic Surgery Market Assessment, By Component Type, By Technology, By Anatomy, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
全球骨科手术 AI 市场预计将从 2024 年的 3.0758 亿美元增长到 2032 年的 27.435 亿美元,在 2025-2032 年预测期内的复合年增长率为 32.03%。市场的成长受到老年人口增加、骨科手术数量的增加、医疗保健领域对基于人工智慧的技术的应用增加以及对微创手术的需求不断增长等因素的推动。医疗保健预算的增加、公共和私人机构的投资增加、政府措施和技术进步进一步推动了全球骨科手术人工智慧市场的成长。
此外,全球范围内骨科手术的数量正在增加,因此全球骨科手术人工智慧市场正在大幅增长。人口老化更容易出现与骨骼相关的健康问题,如关节炎、骨折、关节痛、发炎和脊椎畸形,增加了骨科手术的需求。为了提高效率并满足日益增长的骨科手术需求,人工智慧正在被整合到手术设备中,并在手术过程中发挥协助外科医生的关键作用,从而缩短手术时间、改善决策、加快恢復时间并减少术中错误。
2024 年 11 月,英国健康科技创新公司 Definition Health Limited 筹集了 750 万美元(575 万欧元)的种子前资金。该投资将支持该公司的人工智慧平台,该平台融入医疗保健平台并将彻底改变手术工作流程。该平台提供个人化、数据驱动的护理,以提高效率、最大限度地减少併发症并最大限度地提高治疗效果。这项创新大大提高了手术效果并增强了AI手术市场。
所有片段均可在所有地区和国家/地区使用。
第六章 2018-2032 年欧洲骨科手术人工智慧市场展望上述公司尚未根据市场占有率保留订单,并且可能会根据研究工作期间可用的资讯而发生变化。
Global AI in the orthopedic surgery market is projected to witness a CAGR of 32.03% during the forecast period 2025-2032, growing from USD 307.58 million in 2024 to USD 2,743.5 million in 2032. Growth in the market is driven by factors such as the increasing geriatric population, increasing number of orthopedics surgeries, growing adoption rate of AI-based technologies in healthcare settings, and growing demand for minimally invasive surgeries. The expanding healthcare budget, increasing investments by public and private organizations, government initiatives, and technological advancements are further accelerating the growth of global AI in the orthopedic surgery market.
Also, global AI in the orthopedic surgery market is undergoing significant growth due to the increasing number of orthopedic surgeries globally. The geriatric population is vulnerable to developing bone-related health conditions, such as arthritis, fractures, joint pain, inflammation, and deformities in the spine, due to which there is a growing demand for orthopedics surgeries. To increase efficiency and meet the growing demand for orthopedic surgeries, AI is being integrated into surgical devices, which plays an essential role by assisting surgeons during surgical procedures, leading to less time, improved decision-making, faster recovery time, and reduction in errors during surgeries.
In November 2024, Definition Health Limited, a UK-based Health Tech innovator, raised USD 7.5 million (5.75 million euros) in pre-seed funding. This investment boosts their AI-powered platform, which fits well into healthcare platforms and revolutionizes surgical workflows. The platform provides individualized, data-led care, enhancing efficiency, minimizing complications, and maximizing outcomes. This innovation has dramatically evolved surgical outcomes and strengthened the AI surgical market.
Growing Volume of Orthopedic Surgeries
There has been a surge in demand for AI in orthopedic surgery due to the rising number of orthopedic surgeries such as total joint arthroplasty, total hip arthroplasty, and total knee arthroplasty. The rise in the aging population and the increased prevalence of musculoskeletal conditions, such as osteoarthritis and rheumatoid arthritis, along with the growing demand for minimally invasive surgeries, are the factors contributing to the growth of orthopedic surgeries. According to the world's largest medical association of musculoskeletal specialists, "The American Academy of Orthopaedic Surgeons (AAOS)", by the year 2050, the demand for orthopedic surgeons is going to increase tremendously due to the increasing number of orthopedic surgeries such as total joint arthroplasty. It also states that increasing the number of surgeons by 10% every five years will be crucial to meet the growing demand for surgeons. As the ratio of surgeons concerning the number of surgeries is very low, the demand for AI-based orthopedic surgery is expected to increase to reduce the burden on orthopedic surgeons.
Increasing Adoption of AI-Based Orthopedic Surgeries
With the increased demand for AI-based orthopedic surgeries, the key market players have significantly increased the adoption of AI-based orthopedic surgical software and hardware solutions. The deployment and use of AI in orthopedic surgeries are expected to increase due to the increasing number of orthopedic surgeries and the lack of orthopedic surgeons. Additionally, there has been a surge in investments in AI-based orthopedic surgeries. Brain and Company stated that investments in AI-based orthopedic surgeries have increased in recent years due to improved precision, efficient preoperative planning, and improved decision-making with the help of AI-based navigation systems during surgery.
Moreover, these solutions reduce the risk of complications during surgery and improve patient outcomes, which is why global AI in orthopedic surgery is flourishing. Several leading players, such as Stryker Corporation and Zimmer Biomet Holdings Inc., are continuously involved in bringing innovative AI-based orthopedic surgery solutions, whereas large companies, like Johnson & Johnson, are expanding their market in this industry through mergers & acquisitions and partnerships with the start-ups and medical device companies in this space.
Software Holds the Highest Share in AI Based Orthopedic Surgery Market
Amongst component types, software-based solutions dominate the overall market. AI-based orthopedic software plays a pivotal role in orthopedic surgeries. Software is responsible for preoperative planning and guides surgeons during surgery by providing real-time feedback, which reduces the chances of errors and the possibility of infection on the surgical site. These solutions improve instrument positioning, enhance surgical precision, and increase overall efficiency in orthopedic surgeries. Due to this, key market players are developing AI-based orthopedic software to fulfill the increasing demand for surgeries. In July 2023, Stryker Corporation launched a highly efficient surgical planning and guidance software, named the "Ortho Q Guidance system," for various orthopedic surgeries such as hip and knee surgical procedures. The guiding system uses a smart, streamlined platform to provide surgical planning and intraoperative guidance to improve knee and hip surgical procedures and increase the speed and outcome of the surgery.
Knee Surgeries are Growing at a Rapid Rate
The rise in the number of orthopedic surgeries in the lower extremities, such as partial knee replacement, total knee replacement, and ligament surgeries, along with significant investments by key players in the segment, is driving the demand for knee surgeries in AI-based orthopedic surgeries. Moreover, several leading players are launching AI-based orthopedic surgery for lower extremities in their product portfolio. In October 2023, Johnson & Johnson MedTech launched the "VELYS Robotic-Assisted Solution" from DePuy Synthes for its European market. It is an innovative digital surgery platform specifically designed for total knee arthroplasty. With its launch, DePuy Synthes enhanced its digital surgery platform to manage the growing need for knee surgeries, which are difficult to treat by traditional methods. The supportive regulatory system and increased demand for knee surgeries, along with increasing research and development in this segment, further enable growth in global AI in the orthopedic surgery market.
North America Holds the Largest Share Globally
North America holds the maximum share of global AI in the orthopedic surgery market due to its robust healthcare infrastructure, availability of advanced technologies within healthcare facilities, and high adoption rate of AI-based technologies. The demand for AI-based orthopedic surgery is accelerating to overcome the lack of surgeons and reduce the burden on existing surgeons in North America. In August 2024, Zimmer Biomet Holdings, Inc. acquired OrthoGrid Systems, Inc., a Utah-based company specializing in AI-driven surgical guidance of hip replacements, one of the medical technology companies in North America with a notable market share in the AI orthopedic surgery market. Zimmer Biomet enhances its hip portfolio by meeting the growing need for fluoroscopy-based solutions while improving intraoperative efficiency and patient outcomes. Moreover, the presence of medical device and IT companies such as Intuitive Surgical Inc., Globus Medical, Inc., IBM Corporation, and Microsoft Corporation in North America further facilitates the growth of global AI in orthopedic surgery market.
Future Market Scenario (2025-2032F)
The global AI in orthopedic surgery market is expected to grow in the future due to several factors. The increasing number of orthopedic surgical procedures worldwide has increased the demand for AI in orthopedic surgery, and integration of AI in surgical procedures reduces the burden on surgeons and improves surgical outcomes. The increasing adoption rate of AI-based orthopedic surgeries globally, along with consistent and frequent product launches by key market players, are propelling the growth of this market. Government initiatives play a significant role in integrating artificial intelligence (AI) in orthopedic surgery. These initiatives can support research, development, and implementation of AI technologies in healthcare. Moreover, collaborative ventures and the entry of new market players will drive growth over the forecast period.
Key Players Landscape and Outlook
AI-based orthopedic surgeries play a crucial role in enhancing the quality and improving the success rate of orthopedic surgeries. Several medical device companies and IT companies are establishing strategic partnerships and collaboration, leading to the growth of global AI in orthopedic surgery market. These collaborations enable the firms to gain information regarding the market and latest technologies, enhance diversification, and improve financial strength. Distribution agreements enable companies to access new markets and broaden their market presence at a global level.
For instance, In September 2024, Stryker Corporation completed the acquisition of care.ai, one of the leading AI companies specializing in ambient intelligent solutions and AI-assisted virtual care workflows. This strategic move will help the company expand its wirelessly connected medical devices portfolio and enhance its healthcare IT solutions.
In June 2024, Zimmer Biomet Holdings, Inc. and RevelAi, Inc. entered a multi-year co-marketing partnership to commercialize generative AI-driven engagement solutions that drive value-based orthopedic care. The firms intend to enhance orthopedic care accessibility and ensure the availability of innovative solutions for the efficient fulfillment of evolving clinical needs.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.